Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

Author:
Date:
16 October 2024
4R4A0991

The 40th Annual Congress and the 23rd consecutive gathering of the Iranian Psychiatric Association took place from October 7 to 10 at Milad Hospital in Tehran, with active participation by ActoverCo.

According to Actover Pharmaceutical Group’s public relations, this year’s congress, titled “Psychiatry for Challenging Times: Empowering Therapists, Supporting Patients,” included 183 scientific lectures and 39 specialized symposia. The event also featured a ceremony honoring veteran psychiatrists and the second edition of the 3-Minute Presentation Competition.

During the congress, the 8th Professor Davidian Award and the 5th Afshin Yadollahi Award were also presented.

In parallel with the congress, training workshops and a specialized pharmaceutical exhibition took place, where Actover Pharmaceutical Group showcased its latest products. Physicians attending the event were updated on and benefited from the newest developments in pharmaceuticals.

Actover’s Psychiatric and Neurological Medications

With over 50 years of experience and state-of-the-art pharmaceutical technology, Actover Pharmaceutical Group offers more than 300 products across 15 medical and therapeutic areas. Psychiatric and neurological medications make up a significant portion of Actover’s product range, including:

Asentra is the brand name for Sertraline, produced by ActoverCo under the license of KRKA, Slovenia. Sertraline is an antidepressant classified as a selective serotonin reuptake inhibitor (SSRI).

Ectopentin is the brand name for Gabapentin, manufactured by ActoverCo. Gabapentin is widely used to treat epilepsy and peripheral neuropathic pain (chronic pain caused by nerve damage).

Lyriver, the brand name for Pregabalin, is produced by ActoverCo. Pregabalin is an anti-epileptic drug used for epilepsy, neuropathic pain, and anxiety disorders.

Loxever, the brand name for Duloxetine, is an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class.

Actoserc, the brand name for Betahistine, is an anti-vertigo medication produced by ActoverCo.

Escitover, the brand name for Escitalopram, is an antidepressant classified as an SSRI.

Tazadep, the brand name for Mirtazapine, is an antidepressant produced by ActoverCo.

Quentiax, the brand name for Quetiapine, is an antipsychotic drug produced by ActoverCo under the license of KRKA, Slovenia.

Yasnal, the brand name for Donepezil, is used in the early stages of Alzheimer’s disease and works by inhibiting acetylcholinesterase to increase acetylcholine levels in the brain.

Arizover, the brand name for Aripiprazole, is an antipsychotic drug produced by Actoverco

Related Posts

M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

4R4A0991

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

WhatsApp Image 2024-09-23 at 10.46.39 AM

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress